Evidence map›Paper›PMID 39670537›Full record

ArticleCNS neuroscience & therapeutics2024

Cell Sheets Formation Enhances Therapeutic Effects of Human Umbilical Cord Mesenchymal Stem Cells on Spinal Cord Injury.

Yulin Zhao, Zhengchao Wu, Yuchen Zhou, Cheng Chen, Yang Lu, Heng Wang, Tao Xu, Changwei Yang, Xiaoqing Chen

Abstract read
In one paragraph

Article in CNS neuroscience & therapeutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yulin ZhaoDepartment of Spine Surgery, Affiliated Hospital of Nantong University, Nantong, China.ORCID 0000-0002-4311-3801
Zhengchao WuDepartment of Spine Surgery, Affiliated Hospital of Nantong University, Nantong, China.
Yuchen ZhouDepartment of Spine Surgery, Affiliated Hospital of Nantong University, Nantong, China.
Cheng ChenDepartment of Spine Surgery, Affiliated Hospital of Nantong University, Nantong, China.
Yang LuDepartment of Spine Surgery, Affiliated Hospital of Nantong University, Nantong, China.
Heng WangDepartment of Spine Surgery, Affiliated Hospital of Nantong University, Nantong, China.
Tao XuMedical School of Nantong University, Nantong, China.ORCID 0000-0002-9169-8752
Changwei YangDepartment of Spine Surgery, Affiliated Hospital of Nantong University, Nantong, China.
Xiaoqing ChenDepartment of Spine Surgery, Affiliated Hospital of Nantong University, Nantong, China.

Funding

Grants from Jiangsu Provincial Research Hospital YJXYY202204Medical Research Projects of the Health Commission of Jiangsu Province K2023006National Natural Science Foundation of China 82371383Postgraduate Research and Practice Innovation Program of Jiangsu Province SJCX24_2061
6 · The paper itself

Abstract

backgroundIn recent years, the utilization of stem cell therapy and cell sheet technology has emerged as a promising approach for addressing spinal cord injury (SCI). However, the most appropriate cell type and mechanism of action remain unclear at this time. This study sought to develop an SCI rat model and evaluate the therapeutic effects of human umbilical cord mesenchymal stem cell (hUC-MSC) sheets in this model. Furthermore, the mechanisms underlying the vascular repair effect of hUC-MSC sheets following SCI were investigated.

methodsA temperature-responsive cell culture method was employed for the preparation of hUC-MSC sheets. The extracellular matrix (ECM) produced by hUC-MSCs serves two distinct yet interrelated purposes. Firstly, it acts as a biologically active scaffold for transplanted cells, facilitating their attachment and proliferation. Secondly, it provides mechanical support and bridges spinal cord stumps, thereby facilitating the restoration of spinal cord function. The formation of the cavity within the spinal cord was evaluated using the Hematoxylin and Eosin (H&E) staining method. Subsequently, endothelial cells were cultivated with the conditioned medium (CM) obtained from hUC-MSCs or hUC-MSC sheets. The pro-angiogenic impact of the conditioned medium of hUC-MSCs (MSC-CM) and the conditioned medium of hUC-MSC sheets (CS-CM) was evaluated through the utilization of the CCK-8 assay, endothelial wound healing assay, and tube formation assay in an in vitro context. The development of glial scars, blood vessels, neurons, and axons in hUC-MSCs and hUC-MSC sheets was assessed through immunofluorescence staining.

resultsIn comparison to hUC-MSCs, hUC-MSC sheets demonstrated a more pronounced capacity to facilitate vascular formation and induce the regeneration of newborn neurons at the SCI site, while also reducing glial scar formation and significantly enhancing motor function in SCI rats. Notably, under identical conditions, the formation of cell sheets has been associated with a paracrine increase in the ability of the cells themselves to secrete pro-angiogenic growth factors. During the course of the experiment, it was observed that the secretion of uPAR was the most pronounced among the pro-angiogenic factors present in MSC-CM and CS-CM. This finding was subsequently corroborated in subsequent experiments, wherein uPAR was demonstrated to promote angiogenesis via the PI3K/Akt signaling pathway.

conclusionThe creation of cell sheets not only significantly enhances the biological function of hUC-MSCs but also effectively retains the cells locally in spinal cord injury. Therefore, the transplantation of hUC-MSC sheets can maximize the function of hUC-MSCs, greatly reducing glial scar formation, enhancing vascular formation, and promoting the regeneration of neurons and axons. Additionally, the research findings prove that hUC-MSC sheets activate the PI3K/Akt signaling pathway through uPAR secretion to enhance angiogenesis. The transfer of the entire extracellular matrix by hUC-MSC sheets, in the absence of the introduction of additional exogenous or synthetic biomaterials, serves to further augment their potential for clinical application.

Indexed as

Mesenchymal Stem CellsMesenchymal Stem Cell TransplantationRats, Sprague-DawleySpinal Cord InjuriesUmbilical CordAnimalsCells, CulturedCulture Media, ConditionedDisease Models, AnimalFemaleHumansNeovascularization, PhysiologicRatsCulture Media, Conditionedangiogenesiscell sheetshuman umbilical cord mesenchymal stem cellsPI3K/Akt pathwayspinal cord injury

Identifiers

PMID39670537
PMCPMC11638885

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.